Rxsight Inc reports results for the quarter ended in December - Earnings Summary

RxSight

29/02/2024 24:39

* Rxsight Inc  RXST.OQ  reported a quarterly adjusted loss
of 26
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -56
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 36 cents per share. Wall Street expected
results to range from -41 cents to -30 cents per share.
    * Revenue rose 77.6% to $28.58 million from a year ago;
analysts
expected $27.86 million. 
    * Rxsight Inc's reported EPS for the quarter was a loss
of 26
cents​.
    * The company reported a quarterly loss of $9.18 million.
    * Rxsight Inc shares had risen by 43.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Rxsight Inc
is
$53.00 

This summary was machine generated from LSEG data February 29 at
12:38 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.36          -0.26          Beat
 Sep. 30 2023      -0.43          -0.31          Beat
 Jun. 30 2023      -0.47          -0.39          Beat
 Mar. 31 2023      -0.53          -0.42          Beat